CA19: Diagnosis of Pancreatic Cancer with CA19-9 Biomarker.

In R4HCR: R for Health Care Research

Diagnosis of Pancreatic Cancer with CA19-9 Biomarker.

Description

Data from a diagnostic accuracy review of imaging techniques and tumor markers for the diagnosis of pancreatic carcinoma.

Usage

CA19

Format

A data frame with 22 observations on the following 5 variables.

study

Name of study.

TP

The number of true positive test results.

FP

The number of false positive test results.

FN

The number of false negative test results.

TN

The number of true negative test results.

Details

Protein cancer antigen 19-9 (CA 19-9) is a test used to monitor response to treatment for cancers such as pancreatic, Bile duct, Colorectal, Stomach, Ovarian and Bladder cancer.

References

Niederau C, Grendell JH. Diagnosis of pancreatic carcinoma. Imaging techniques and tumor markers. Pancreas. 1992;7(1):66-86. \Sexpr[results=rd]{tools:::Rd_expr_doi("doi: 10.1097/00006676-199201000-00011")}. PMID: 1557348.

Examples

require(mada)

data(CA19, package = "R4HCR")

# Bivariate Reitsma model/HSROC analysis.
reitsma(CA19, method = "ml")

R4HCR documentation built on Sept. 30, 2024, 9:46 a.m.